We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

5 hedge funds and large institutions have $177K invested in BioCardia, Inc. Warrant in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

72% less capital invested

Capital invested by funds: $641K → $177K (-$464K)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

BCDAW Hedge Fund Activity: Q1 2022 in Review

5 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q1 2022, worth a combined $177K — down 72% from $641K a quarter earlier.

Fund positioning in BCDAW was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 5 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $177K of BioCardia, Inc. Warrant stock for Q1 2022, down 72% quarter-over-quarter.
  • 0 funds opened new BioCardia, Inc. Warrant positions in Q1 2022 and 0 closed out.

Based on aggregated 13F filings for Q1 2022.